Back
Phathom Pharmaceuticals Stock Price Chart

Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8
PHAT
Phathom Pharmaceuticals
Last Price:
$4.88
Seasonality Move:
17.73%
7 Day Trial
ALL ACCESS PASS
$
7

Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing slight buying pressure.
Phathom Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.77 | Sell |
20-day SMA: | 5.52 | Sell |
50-day SMA: | 5.6 | Sell |
200-day SMA: | 10.69 | Sell |
8-day EMA: | 4.78 | Sell |
20-day EMA: | 5.26 | Sell |
50-day EMA: | 5.92 | Sell |
200-day EMA: | 8.98 | Sell |
Phathom Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.36 | Sell |
Relative Strength Index (14 RSI): | 35.31 | Sell |
Chaikin Money Flow: | 318852 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.59 - 6.25) | Sell |
Bollinger Bands (100): | (5.37 - 8.33) | Sell |
Phathom Pharmaceuticals Technical Analysis
Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 4.11 while PHAT 8-day simple moving average is 4.77, which is a Sell signal.
-
The stock price of PHAT is 4.11 while Phathom Pharmaceuticals 20-day SMA is 5.52, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day simple moving average is 5.60 while PHAT share price is 4.11, making it a Sell technically.
-
PHAT stock price is 4.11 and Phathom Pharmaceuticals 200-day simple moving average is 10.69, creating a Sell signal.
PHAT Technical Analysis vs Fundamental Analysis
Sell
8
Phathom Pharmaceuticals (PHAT)
is a Sell
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a SellThe current Phathom Pharmaceuticals [PHAT] share price is $4.11. The Score for PHAT is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
286.2M
Price in USD:
4.11
Share Volume:
1.3M
Phathom Pharmaceuticals 52-Week Range
52-Week High:
19.71
52-Week Low:
3.81
Sell
8
Phathom Pharmaceuticals (PHAT)
is a Sell
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?The Phathom Pharmaceuticals stock price is 4.11 USD today.
-
Will PHAT stock go up or go down?Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Phathom Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 4.11 while PHAT 8-day exponential moving average is 4.78, which is a Sell signal.
-
The stock price of PHAT is 4.11 while Phathom Pharmaceuticals 20-day EMA is 5.26, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day exponential moving average is 5.92 while PHAT share price is 4.11, making it a Sell technically.
-
PHAT stock price is 4.11 and Phathom Pharmaceuticals 200-day simple moving average is 8.98, creating a Sell signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.22 per share, an increase this year of $0.78 per share, and an increase next year of $2.19 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
-
PHAT Moving Average Covergence Divergence (MACD) indicator is -0.36, suggesting Phathom Pharmaceuticals is a Sell
-
Phathom Pharmaceuticals Relative Strength Index (RSI) is 35.31, which suggest Phathom Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Phathom Pharmaceuticals is (4.59 - 6.25), which suggest Phathom Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Phathom Pharmaceuticals is (5.37 - 8.33), which suggest Phathom Pharmaceuticals is a Sell
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.